Araim Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Araim Pharmaceuticals

Access the complete profile.

Araim Pharmaceuticals Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	580 White Plains Rd #210 Tarrytown, NY 10591

Note: Revenues for privately held companies are statistical evaluations.


Araim Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Araim Pharmaceuticals's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Araim Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Araim Pharmaceuticals Annual Revenue and Growth Rate

Araim Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Araim Pharmaceuticals's revenues are gauged from an analysis of company filings.

Araim Pharmaceuticals's Income Statement (based on Industry Averages)

Araim Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Araim Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
November 15, 2017	5	100%	$4 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Araim Pharmaceuticals is developing and marketing. Araim Pharmaceuticals doesn't have any recent trademark applications, indicating Araim Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ARAIM Pharmaceutical preparations for activation of tissue repair and inhibition of inflammatory mechanisms	06/03/2016

See all trademarks and details in the Full Report.

Market Share of Araim Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Araim Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Araim Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
REGENERON PHARMACEUTICALS	Tarrytown, NY	100
FUJIFILM DIOSYNTH BIOTECHNOLOGIES U.S.A.	Valhalla, NY	20
WELEDA	Irvington, NY	0
FUJIFILM WAKO DIAGNOSTICS U.S.A.	Valhalla, NY	0
ARMONK PHYSICAL THERAPY & SP	Armonk, NY	0
ARAIM PHARMACEUTICALS	Tarrytown, NY	0

Future Competition: Araim Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Araim Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)